INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
103 hedge funds and large institutions have $94.2M invested in Insys Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less call options, than puts
Call options by funds: $3.55M | Put options by funds: $6.18M
Holders
103
Holding in Top 10
–
Calls
$3.55M
Puts
$6.18M
Top Buyers
| 1 | +$1.4M | |
| 2 | +$1.23M | |
| 3 | +$1.1M | |
| 4 |
JG
Jefferies Group
New York
|
+$371K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$369K |
Top Sellers
| 1 | -$3.56M | |
| 2 | -$1.47M | |
| 3 | -$1.04M | |
| 4 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$399K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$392K |